PE/TR Anti-Human CD22 Antibody[BU59]

Introducing the PE/TR Anti-Human CD22 Antibody [BU59], a highly advanced and meticulously developed product designed to revolutionize the field of immunology. This cutting-edge antibody is specifically engineered to target the CD22 antigen, a cell surface glycoprotein predominantly expressed on B cells.

Crafted with utmost precision and expertise, the PE/TR Anti-Human CD22 Antibody [BU59] exhibits exceptional binding affinity and specificity towards the CD22 antigen, enabling accurate and reliable detection and analysis of B cells in various research applications.

With its unique combination of phycoerythrin (PE) and tandem dye (TR), this antibody offers unparalleled versatility and flexibility in experimental design. The PE/TR conjugation ensures enhanced signal detection and allows for multiparametric flow cytometry analysis, facilitating comprehensive characterization of B cell populations.

Furthermore, the PE/TR Anti-Human CD22 Antibody [BU59] showcases exceptional performance in immunofluorescence staining, making it an indispensable tool for immunohistochemistry and immunocytochemistry studies. Its robust and consistent results guarantee reproducibility and accuracy, empowering researchers to delve deeper into the intricacies of B cell biology.

In addition to its exceptional scientific capabilities, this antibody is manufactured under stringent quality control measures, ensuring utmost purity, stability, and reliability. Each batch undergoes rigorous testing to meet the highest industry standards, guaranteeing consistent and reproducible results.

The PE/TR Anti-Human CD22 Antibody [BU59] is poised to revolutionize the field of immunology, offering researchers an invaluable tool to unravel the complexities of B cell biology. With its unrivaled performance, versatility, and reliability, this antibody is a must-have for any laboratory seeking to advance their understanding of B cell-related diseases and therapeutic interventions.